Lenabasum Improved Skin Symptoms, in Small Dermatomyositis Trial
In the phase 2 trial, skin biopsies before and after treatment showed significant reductions in inflammatory cytokines relevant to dermatomyositis pathogenesis.
Source: medscape.com
Page 20 - Systemic Sclerosis News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Systemic Sclerosis. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Systemic Sclerosis Today - Breaking & Trending Today
Cumberland Pharmaceuticals Reports 6% Revenue Growth
/PRNewswire/ -- Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX), a specialty pharmaceutical company today announced that the Company's product portfolio of...
Source: prnewswire.com
Cumberland Pharmaceuticals Announces Key Co-Promotion Agreement with Verity Pharmaceuticals to Expand Support for Sancuso®
/PRNewswire/ -- Specialty pharmaceutical company Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX) announced today that it has entered into a national...
Source: prnewswire.com
Worldwide Systemic Scleroderma Treatment Industry to 2028 - Featuring Bristol-Myers Squibb, GlaxoSmithKline and Corbus Pharmaceuticals Among Others
/PRNewswire/ -- The "Systemic Scleroderma Treatment Market, by Drug Class, by Disease Type, by Route of Administration, by Distribution Channel, and by Region...
Source: prnewswire.com
Outlook on the Systemic Scleroderma Treatment Global Market
Dublin, May 04, 2022 (GLOBE NEWSWIRE) -- The "Systemic Scleroderma Treatment Market, by Drug Class, by Disease Type, by Route of Administration, by...
Source: globenewswire.com